JCA

Market Access

At ISPOR EU 2025, a cross-stakeholder panel addressed how Joint Clinical Assessment under the EU HTA Regulation is reshaping evidence strategies.

Market Access

New policies are shaping the market access landscape, such as the introduction of the EU HTA for oncology medicines.

Market Access

In a new pharmaphorum podcast, Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discusses Joint Clinical Assessments.

Digital

Changes to Health Technology Assessment in Europe offer new opportunities to streamline processes and get innovative treatments to market faster

Views & Analysis

The long road to unified European Health Technology Assessment (HTA) is continuing.